Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan.
- DOI
- 10.1515/cclm-2025-1270
- Published
- 2026 May 26
- Container
- Clinical chemistry and laboratory medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1515/cclm-2025-1270,
title = {Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan.},
author = {Langemeijer SMC and Langereis JD and Avest MT and Duineveld C and van de Logt AE and De Kat Angelino CM and van Deelen A and Michels MAHM and Gloerich J and Sprenkeler EGG and van der Molen RG and van de Kar NCAJ and Jacobs JFM},
year = {2026},
journal = {Clinical chemistry and laboratory medicine},
doi = {10.1515/cclm-2025-1270},
url = {https://doi.org/10.1515/cclm-2025-1270}
}RIS
TY - JOUR TI - Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan. AU - Langemeijer SMC AU - Langereis JD AU - Avest MT AU - Duineveld C AU - van de Logt AE AU - De Kat Angelino CM AU - van Deelen A AU - Michels MAHM AU - Gloerich J AU - Sprenkeler EGG AU - van der Molen RG AU - van de Kar NCAJ AU - Jacobs JFM PY - 2026 JO - Clinical chemistry and laboratory medicine DO - 10.1515/cclm-2025-1270 UR - https://doi.org/10.1515/cclm-2025-1270 ER -
APA
SMC, L., JD, L., MT, A., C, D., AE, V. D. L., CM, D. K. A., A, V. D., MAHM, M., J, G., EGG, S., RG, V. D. M., NCAJ, V. D. K., & JFM, J. (2026). Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan.. Clinical chemistry and laboratory medicine. https://doi.org/10.1515/cclm-2025-1270
Source records
- pubmed · retrieved 2026-09-26T09:20:22.374Z